Myles Wolf
Department Chair
Credentials: · · ·
History
- Present
Research
Vitamin D deficiency and risk of cardiovascular disease
Circulation · 2008 · 1,752 citations
FGF23 induces left ventricular hypertrophy
Journal of Clinical Investigation · 2011 · 1,632 citations
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
New England Journal of Medicine · 2008 · Last of 11 authors · 1,376 citations
101 papers · 23 as a resident
39 papers · 8 as a fellow
37 papers
33 papers · 5 as a fellow
- RT
33 papers
24 papers
23 papers
22 papers
Grants
- 2023–2027
Tissue-Specific Regulation and Effects of CYP24A1
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2M · Weill Medical Coll of Cornell Univ
- 2019–2024
National Institute of Diabetes and Digestive and Kidney Diseases · UH3
Contact PI · $5.4M · Duke University
- 2008–2019
FGF23 and Cardiovascular Disease in CKD
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $4.2M · Duke University
- 2018–2019
National Institute of Diabetes and Digestive and Kidney Diseases · UG3
Contact PI · $842K · Duke University
Clinical trials
- 2022–2026
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Principal investigator · Terminated · Phase 2
Duke University
- 2020–2023
HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis
Principal investigator · Terminated
Duke University
- 2009–2012
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Principal investigator · Completed
Myles Wolf
- 2007–2010
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
Principal investigator · Completed
Massachusetts General Hospital